Efficacy of 0.38% and 0.18% Sodium Hyaluronate Ocular Lubricants for Dry Eye in Adult Gazan Participants

PHASE2CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

October 30, 2022

Primary Completion Date

February 3, 2023

Study Completion Date

February 3, 2023

Conditions
Dry Eye
Interventions
DRUG

0.38% Sodium Hyaluronate (SH) Eye Drops

"A lubricant eye drop containing 0.38% sodium hyaluronate (SH), designed to improve tear film stability and ocular surface health in individuals with moderate to severe dry eye disease (DED).~The formulation has a higher viscosity and retention time, potentially offering better symptom relief for evaporative dry eye (EDE)."

DRUG

0.18% Sodium Hyaluronate Eye Drops

"A lubricant eye drop containing 0.18% sodium hyaluronate (SH), used to alleviate dry eye symptoms and improve tear film stability.~This formulation has a lower viscosity compared to 0.38% SH, potentially providing faster absorption but with shorter ocular surface retention."

DRUG

Normal Saline Eye Drops

"A non-active control treatment consisting of sterile normal saline (0.9% NaCl) used as a placebo comparator.~It provides temporary moisture but lacks the viscoelastic and therapeutic properties of sodium hyaluronate."

Trial Locations (1)

PO Box 108

Islamic University of Gaza (IUG), Gaza

All Listed Sponsors
collaborator

Islamic University of Gaza, Gaza, Palestine

UNKNOWN

lead

International Islamic University Malaysia

OTHER